- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 21, 2026 | 12.51M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 12.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 12.84M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $133.93M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $170.27M |
| Capex | Q1 2026 · Mar 31, 2026 | $47.27M |
| Capex | Q1 2026 · Mar 31, 2025 | $40.71M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $15.91M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $376.19M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $4.38B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $4.3B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.68B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.96B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $18.13B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.6B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $49.95B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $49.8B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $68.6B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $68.91B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$18.90 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $12.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$18.90 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $12.11 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$212.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | $121.71M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$273.33M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $282.52M |